Treatment with 5 mu M of saikosaponin (SS) b(2) for 30 days was found to in
duce differentiation of B16 melanoma cells, with potentiation of expression
s of melanogenesis and tyrosinase. To explore the mechanism of this effect,
we observed the cell growth, cell cycle and morphology, and found that SSb
2 did not affect any of these parameters. That is, SSb2 induced the differe
ntiation of B16 melanoma cells without growth inhibition or cytotoxicity un
der conditions of low dose and long-term treatment. Phorbol ester, a protei
n kinase C (PKC) activator, markedly inhibited the expressions of melanogen
esis and tyrosinase in both the control B16 melanoma cells and the long-ter
m treated B16 melanoma cells. Down-regulation of the PKC activity may be in
volved in the effects of SSb2.